Clinical Trials Directory

Trials / Completed

CompletedNCT05468827

ICG Fluorescence Guided Lymph Node Mapping for Determination of Bowel Resection Margins in Colon Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
108 (actual)
Sponsor
N.N. Petrov National Medical Research Center of Oncology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study is aimed at investigating feasibility of defining colon resection margins for colon cancer with ICG by comparing lymphatic distribution of subserosally injected dye with actual spread of lymphatic metastases reported by pathologists after specimen examination

Detailed description

In this study 2.5 mg/ml indocyanine green solution is injected subserosally into colonic wall near the tumour in 4 points (1 ml each). The fluorescence is assessed before specimen removal (at least 30 min after injection) and its mesenteric distribution is marked by surgeon on the specimen. Proximal and distal colonic resection margins are chosen to be at least 10 cm long and to include the whole area of fluorescence. After removal, lymphatic node groups according JSCCR are also marked on fresh specimen. During pathological examination each lymph node is assessed not only for presence of metastases but also for its exact location in relation to margins of indocyanine distribution.

Conditions

Interventions

TypeNameDescription
PROCEDURElymphatic mapping with indocyanine greensubserosal injection of indocyanine green near the primary tumour with subsequent assessment of the dye spread along lymphatics

Timeline

Start date
2022-07-26
Primary completion
2024-02-27
Completion
2024-03-14
First posted
2022-07-21
Last updated
2025-06-26

Locations

1 site across 1 country: Russia

Source: ClinicalTrials.gov record NCT05468827. Inclusion in this directory is not an endorsement.